4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1)

Request For Quotation
4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) Suppliers list
Company Name: Jilin Shengchuang Biotechnology Co., LTD  
Tel: 13251734045; 13251734045
Email: 396921152@qq.com
Company Name: EMERTH  
Tel: 19011298796 19011298796
Email: 17816380947@139.com
Company Name: Zhejiang Huida Biotech Co., Ltd.  
Tel: 0571-89903022 18679456698
Email: zilong@hizyme.com
4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) Basic information
Product Name:4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1)
Synonyms:4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1);TLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride;1-(4-(4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-8-yl)piperazin-1-yl)-3,6,9,12,15,18,21,24,27,30-decaoxatritriacontan-33-oic acid hydrochloride
CAS:2388520-36-1
MF:C41H69ClN6O12
MW:873.48
EINECS:
Product Categories:ADC/XDC
Mol File:2388520-36-1.mol
4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) Structure
4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) Chemical Properties
Safety Information
MSDS Information
4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) Usage And Synthesis
UsesTLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride (compound 9) is a drug-linker conjugates for ADC with potent antitumor activity by using TLR7/8 agonist 4 (HY-139018; a TLR7/8 agonist), linked via the non-cleavable ADC linker hydroxy-PEG10-acid (HY-133307)[1].
IC 50Traditional Cytotoxic Agents
References[1] Shelley Erin ACKERMAN, et al. Immunoconjugates targeting her2. WO2020190725A1.
4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) Preparation Products And Raw materials
Tag:4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1)(2388520-36-1) Related Product Information
Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]- L-Ornithinamide, N6-[39-[bis(1-deoxy-D-glucitol-1-yl)amino]-1-oxo-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxanonatriacont-1-yl]-N2-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-lysyl-L-valyl-N5-(aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-1... PSMA-617 L-Ornithinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]methyl]phenyl]- Val-Cit-PAB-MMAE Mal-VC-PAB-DM1